4 10, 2024

Qkine integrates the latest advancement in fill-finish automation into its recombinant protein manufacturing process

2024-10-07T14:24:03+00:00October 4th, 2024|Blog, News, quality|

Our latest investment in our mission at Qkine to produce the highest quality growth factors for research. The most state-of-the-art automated system which fills, labels and caps vials with minimal manual intervention.

16 08, 2024

Qkine is pleased to announce that it has been recertified with the international standard ISO 9001:2015 by globally respected UKAS-accredited BSI

2024-10-10T08:20:51+00:00August 16th, 2024|Awards, cellular agriculture, News, Press Release, quality|

Qkine is pleased to announce that it has successfully been recertified with the international standard ISO 9001:2015 by the globally respected UKAS accredited BSI, giving enhanced confidence in the assessment of best practices. This standard shows our dedication to raising the standard of bioactive proteins through implementation of continual improvement, scientific innovation and exceptional scientific and customer support

24 07, 2024

ISSCR 2024 reflections on “Standards for Human Stem Cell Use in Research” and growth factors for cell therapy manufacture

2024-07-25T16:45:56+00:00July 24th, 2024|animal-free, Blog, News, protein science, quality, Resources, stem cells|

Reflections on the dynamic ISSCR 2024 workshop on Standards for Human Stem Cell Use in Research including recommendations for growth factor supply chains for raw (ancillary materials) for cell therapy and ATMP manufacture.

24 07, 2024

The Cautionary Tale of GDF-15

2024-07-25T06:11:35+00:00July 24th, 2024|animal-free, Blog, News, protein science, quality, Resources|

Commercial sources of recombinant human GDF15 protein, in particular those purified from mammalian expression, are frequently contaminated with trace amounts of TGFβ and related proteins. These trace contaminants cause misleading experimental results due to the picomolar or even femtomolar EC50s of this family of cytokines.  Please be cautious with your source of recombinant GDF15 protein.

9 07, 2024

Qkine and StemCultures collaborate to provide new solutions for precision stem cell culture

2024-07-09T16:09:20+00:00July 9th, 2024|animal-free, Blog, News, Press Release, protein engineering, protein science, quality, Resources, stem cells|

Specialist bioactive growth factor protein manufacturer Qkine today announced a new partnership with StemCultures, a life sciences company dedicated to developing innovative reagents that enhance the quality and efficiency of cell growth and differentiation in culture.

10 09, 2021

Qkine earns ISO 9001:2015 certification for protein R&D and manufacture facilities in Cambridge, UK

2024-08-15T06:47:24+00:00September 10th, 2021|Awards, cellular agriculture, News, Press Release, quality|

Qkine certified ISO9001: 2015 for its quality management system encompassing R&D, manufacturing, and operations in Cambridge, UK. Qkine supplies growth factors and cytokines to the fast-moving stem cell, organoid and emerging cultured meat sectors. Exceptional product quality and scientific support are crucial to customer's business processes and experimental outcomes.

12 07, 2021

mouse LIF protein vs ESGRO?

2023-11-23T14:38:10+00:00July 12th, 2021|#qkinetechtip, protein science, quality, Resources, stem cells|

There is no fundamental difference between ESGRO and recombinant mouse leukaemia inhibitor factor (mLIF) protein. Both can be used for the successful maintenance of mouse embryonic stem cell (ESC) pluripotency. 10E7 units of ESGRO is equivalent to 100 µg of pure protein. Thank you to Susanne van den Brink (postdoc in Anna Bigas lab, IMIM, Barcelona) and David Turner (University of Liverpool) for sharing their resuspension protocol to prepare ESLIF media.

9 11, 2020

Organoid Q&A with industry experts from the HUB, CSHL and Stemnovate

2022-02-07T13:18:02+00:00November 9th, 2020|organoid news, quality, Resources|

Organoid Q&A with industry experts from the HUB, CSHL and Stemnovate We recently held a webinar with CytoSMART and organoid pioneers from Cold Spring Harbor Laboratory, Stemnovate and the Hubrecht Organoid Technology titled: what's needed to realize the potential of organoids? Following presentations from our speakers, we held an insightful [...]

14 10, 2020

On-demand webinar: What’s needed to realise the potential of organoids?

2022-02-07T13:09:14+00:00October 14th, 2020|organoid news, quality, Resources|

On-demand webinar: What’s needed to realise the potential of organoids? From standardization of imaging techniques, to more reproducible and cost-effective organoid culture media Organoids have the potential to revolutionize current drug discovery approaches, enhance the physiological relevance of in vitro disease models, and deliver on the promise of precision medicine. But, [...]

26 08, 2020

Implementing animal-free recombinant proteins into stem cell supply chains

2022-02-07T13:06:59+00:00August 26th, 2020|animal-free, protein engineering, quality, stem cells|

Implementing animal-free recombinant proteins into stem cell supply chains Most industries today are under pressure to switch to more ethical and sustainable animal-free alternatives, and now the trend is coming to stem cell labs. As stem cell applications accelerate towards the clinic, novel drug discovery platforms are rapidly scaled, and [...]

Go to Top